REACH research team

Nadine earned a Bachelor of Science in Nursing from the University of Pennsylvania in 1998. She went on to earn both a Master’s in Public Health (2002) and medical degree (2003) from Johns Hopkins University Bloomberg School of Public Health and School of Medicine, respectively. She completed residency in internal medicine at Johns Hopkins Hospital in 2006 and fellowship in clinical hematology and oncology at Dana-Farber/Partners CancerCare in 2009. Nadine joined the staff of Dana-Farber Cancer Institute and Brigham and Women’s Hospital in 2009 where she is a medical oncologist and clinical investigator. Her research is focused on improving health and treatment outcomes for older patients with cancer.

Tammy joined the Division of Aging at Brigham and Women’s Hospital in July 2013. She is board-certified in geriatrics and internal medicine. Clinically, she is committed to providing optimal care for the aging population, as an advocate for her patients and preserving holistic quality of their lives. Her research interests are in delirium and cognitive disorders of aging. She has additional expertise and interest in frailty and geriatric oncology. She divides her clinical responsibilities as Associate Physician between the Older Adult Hematologic Malignancy Program at the Dana-Farber Cancer Institute and the Geriatric-Orthopedic inpatient collaboration at the Brigham and Women’s Hospital.

Tamryn is a postdoctoral research fellow at Dana-Farber Cancer Institute within the Department of Psychosocial Oncology and Palliative Care. She earned her undergraduate and MSN degrees from the University of North Carolina at Chapel Hill and her Ph.D. from Johns Hopkins University. She has published peer-reviewed articles and co-authored book chapters on topics related to solid tumors, hematologic malignancies with a special emphasis on patients undergoing hematopoietic stem cell transplantation, and family caregivers of people with cancer. She has received predoctoral and postdoctoral fellowships from the Robert Wood Johnson Foundation and is a current Hospice and Palliative Nurses Association Research Scholar. She also serves as the Co-Chair for the Caregiver Special Interest Group within the American Psychosocial Oncology Society. Her clinical expertise is hematology/oncology and blood and marrow transplantation, and she spent several years practicing in these areas at Duke University Hospital. Tamryn is the recipient of grant funding from the Oncology Nursing Foundation and the American Cancer Society, and her dissertation study examined the role of decision partners in clinical trial decision-making for adults with cancer.

Jiping is a surgical oncologist in the Division of Surgical Oncology at Brigham and Women’s Hospital and the Gastrointestinal Cancer Treatment Center at Dana-Farber Cancer Institute. His clinical interest is gastrointestinal cancer surgery. Jiping’s academic education includes medical education at Henan Medical University, and a PhD in Biostatistics from the University of Pittsburgh.

Jiping has been involved in cancer research for more than 10 years. He had five years’ experience in designing, conducting and reporting phase III clinical trials at National Adjuvant Breast and Bowel Project (NSABP). His research regarding prognostic factor and cancer staging received three awards from American Society of Clinical Oncology foundation and one grant support from American Medical Association.

Jeffrey received his MD from Yale School of Medicine in 1997. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, followed by a medical oncology fellowship at DFCI. He joined the Gastrointestinal Cancer Center at DFCI in 2002.

Kathleen earned a Bachelor’s of Science in Biology and Environmental Science from Fordham University in 2006. She went on to earn a Master of Medical Science through the Yale School of Medicine Physician Associate Program in 2011. She has been working at the Dana-Farber/Brigham and Women’s Cancer Center since 2013, where she initially started on the inpatient solid tumor medical oncology PA team, then with the outpatient thoracic oncology team, and now with the gastrointestinal oncology team. She has recently been accepted to the Doctorate of Science in Physician Assistant Studies program at Massachusetts College of Pharmacy and Health Sciences and will start working on this degree in January 2021.

Rachel completed her MPH in 2017 at the University of Rochester School of Medicine and Dentistry, with a focus on qualitative research and social determinants of health. She previously worked as a Population Health Specialist in Primary Care at Boston Medical Center and as a research associate at a non-profit organization focused on patient engagement in clinical research. Rachel has extensive patient contact experience and enjoys working with older adults in particular.